Ge Healthcare Technologies INC 10-Q quarterly reports

GE HealthCare reported a 5.7% increase in total revenues for Q2 2026, driven by its Advanced Imaging Solutions and Pharmaceutical Diagnostics segments, though net income attributable to GE HealthCare saw a decrease.

GE HealthCare reported a 7.4% increase in total revenues for Q1 2026, reaching $5.13 billion, but net income attributable to GE HealthCare decreased by 31.0% to $389 million.

GE HealthCare Technologies Inc. reported a 6% increase in Q3 revenues to $5.14 billion, but net income attributable to the company declined 5% to $446 million, impacted by cost inflation and tariffs.

GE HealthCare Technologies Inc. reported increased revenues, net income, and earnings per share for the second quarter and first half of 2025, driven by service growth and strategic acquisitions, despite macroeconomic headwinds and tariff impacts.

GE HealthCare Technologies Inc. announces its Q1 2025 financial results, including revenue growth and the acquisition of the remaining stake in Nihon Medi-Physics.

GE HealthCare's Q3 2024 results show a slight revenue increase but are impacted by challenges in the China market and ongoing global economic uncertainties.

GE HealthCare's Q2 2024 results show flat revenue year-over-year but improved profitability driven by cost management and pricing.

GE HealthCare's first quarter results show a slight revenue decrease and increased R&D spending, while navigating global economic and supply chain complexities.